期刊
BRAIN RESEARCH BULLETIN
卷 151, 期 -, 页码 25-37出版社
PERGAMON-ELSEVIER SCIENCE LTD
DOI: 10.1016/j.brainresbull.2018.10.014
关键词
Alzheimer's disease; Neuroinflammation; P1 receptor; P2X receptor; P2Y receptor
资金
- National Institutes of Health [AG018357, DE017591, DE07389]
- BrightFocus Foundation [A20131715]
- Missouri Spinal Cord Research Program
- Food for the 21st Century Program of the University of Missouri
Alzheimer's disease (AD) is a progressive neurodegenerative disorder that is characterized by three major histopathological markers: amyloid-beta (A beta) plaques, neurofibrillary tangles and gliosis in the central nervous system (CNS). It is now accepted that neuroinflammatory events in the CNS play a crucial role in the development of AD. This review focuses on neuroinflammatory signaling mediated by purinergic receptors (P1 adenosine receptors, P2X ATP-gated ion channels and G protein-coupled P2Y nucleotide receptors) and how therapeutic modulation of purinergic signaling influences disease progression in AD patients and animal models of AD.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据